Presentations

Title File Size Download

Ohtuvayre TM FDA Approval Presentation June 2024

2.0MB

PDF

VRNA Presentation August 2024

2.0MB

PDF

Developing novel therapeutics for respiratory diseases

Verona Pharma (Nasdaq:VRNA) is focused on delivering our strategy and creating value for shareholders.